Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients
暂无分享,去创建一个
Matthew L Faron | Blake W Buchan | Nathan A Ledeboer | N. Ledeboer | L. Munoz-Price | B. Buchan | M. Faron | Jessica S Hoff | Cameron G Gmehlin | Adriana Perez | L Silvia Munoz-Price | C. Gmehlin | Jess Hoff | Adriana Perez
[1] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[2] A. Harrington,et al. Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients , 2020, Journal of Clinical Microbiology.
[3] Lowell Ling,et al. Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19 , 2020, Journal of Infection.
[4] Bingliang Zeng,et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? , 2020, European Journal of Radiology.
[5] Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories , 2020, Journal of Clinical Microbiology.
[6] Deborah Schron,et al. Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2 , 2020, Journal of Clinical Microbiology.
[7] Eileen M. Burd,et al. Validation of Laboratory-Developed Molecular Assays for Infectious Diseases , 2010, Clinical Microbiology Reviews.
[8] M. Loda,et al. Comparison of Two High-Throughput Reverse Transcription-PCR Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Journal of Clinical Microbiology.
[9] Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens , 2020, Journal of Clinical Microbiology.
[10] R. Lu,et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.
[11] A. Kamimoto,et al. Saliva-based PCR tests for SARS-CoV-2 detection. , 2020, Journal of oral science.
[12] A M Caliendo,et al. Interlaboratory Comparison of Cytomegalovirus Viral Load Assays , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] J. A. Mays,et al. Detection of SARS-CoV-2 by bronchoscopy after negative nasopharyngeal testing: Stay vigilant for COVID-19 , 2020, Respiratory Medicine Case Reports.
[14] D. Vojta,et al. Patient-collected tongue, nasal, and mid-turbinate swabs compared to health care worker-collected nasopharyngeal swabs for COVID-19 testing , 2020, The New England Journal of Medicine.
[15] B. Pritt,et al. Precision across the Analytical Measuring Range of a Quantitative Real-Time PCR Assay for Cytomegalovirus Detection among Three Clinical Laboratories , 2011, Journal of Clinical Microbiology.
[16] L. Kucirka,et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.
[17] Q. Tao,et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases , 2020, Radiology.
[18] C. Schmotzer,et al. Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 , 2020, Journal of Clinical Microbiology.